- Home
- HOTH vs BGI Comparison
HOTH vs BGI Comparison
Compare HOTH & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- BGI
- Stock Information
- Founded
- HOTH 2017
- BGI 1879
- Country
- HOTH United States
- BGI Canada
- Employees
- HOTH N/A
- BGI N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- BGI
- Sector
- HOTH Health Care
- BGI
- Exchange
- HOTH Nasdaq
- BGI Nasdaq
- Market Cap
- HOTH 15.6M
- BGI 15.9M
- IPO Year
- HOTH 2019
- BGI 2005
- Fundamental
- Price
- HOTH $1.60
- BGI $0.84
- Analyst Decision
- HOTH Strong Buy
- BGI
- Analyst Count
- HOTH 3
- BGI 0
- Target Price
- HOTH $4.00
- BGI N/A
- AVG Volume (30 Days)
- HOTH 1.8M
- BGI 193.1K
- Earning Date
- HOTH 11-11-2025
- BGI 07-25-2025
- Dividend Yield
- HOTH N/A
- BGI N/A
- EPS Growth
- HOTH N/A
- BGI N/A
- EPS
- HOTH N/A
- BGI N/A
- Revenue
- HOTH N/A
- BGI $124,446,731.00
- Revenue This Year
- HOTH N/A
- BGI N/A
- Revenue Next Year
- HOTH N/A
- BGI N/A
- P/E Ratio
- HOTH N/A
- BGI N/A
- Revenue Growth
- HOTH N/A
- BGI N/A
- 52 Week Low
- HOTH $0.65
- BGI $0.56
- 52 Week High
- HOTH $3.80
- BGI $2.45
- Technical
- Relative Strength Index (RSI)
- HOTH 71.15
- BGI 59.75
- Support Level
- HOTH $1.40
- BGI $0.76
- Resistance Level
- HOTH $1.80
- BGI $0.97
- Average True Range (ATR)
- HOTH 0.11
- BGI 0.09
- MACD
- HOTH 0.04
- BGI 0.01
- Stochastic Oscillator
- HOTH 68.75
- BGI 44.20
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.